A 21st Century Response to the Cures Act
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.
From - Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…